Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octohydroaminoacridine succinate vs Donepezil in Mild-to-Moderate Alzheimer's Disease
CTR20160973Phase 3Completed
- Sponsor
- Changchun Huayang High-tech Co., Ltd.
- Start
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of octohydroaminoacridine in Alzheimer's disease (AD), sponsored by Changchun Huayang High-tech Co., Ltd.. Started Jan 2017; status: completed.
02
Drugs
octohydroaminoacridine
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on CTR20160973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160973.